Patents by Inventor Torsten Sejlitz

Torsten Sejlitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040105846
    Abstract: The present invention provides a gene encoding a G protein-coupled receptor termed nGPCR-2067; constructs and recombinant host cells incorporating the genes; the nGPCR-2067 polypeptides encoded by the gene; antibodies to the nGPCR-2067 polypeptides; and methods of making and using all of the foregoing.
    Type: Application
    Filed: October 28, 2003
    Publication date: June 3, 2004
    Inventors: Peter Lind, Torsten Sejlitz, Gabriel Vogeli, Linda S. Wood
  • Publication number: 20030170779
    Abstract: The present invention provides a gene encoding a G protein-coupled receptor termed nGPCR-2644; constructs and recombinant host cells incorporating the genes; the nGPCR-2644 polypeptides encoded by the gene; antibodies to the nGPCR-2644 polypeptides; and methods of making and using all of the foregoing.
    Type: Application
    Filed: April 25, 2001
    Publication date: September 11, 2003
    Inventors: Peter Lind, Torsten Sejlitz, Gabriel Vogeli
  • Publication number: 20030032784
    Abstract: The present invention provides a gene encoding a G protein-coupled receptor termed nGPCR-2067; constructs and recombinant host cells incorporating the genes; the nGPCR-2067 polypeptides encoded by the gene; antibodies to the nGPCR-2067 polypeptides; and methods of making and using all of the foregoing.
    Type: Application
    Filed: May 8, 2001
    Publication date: February 13, 2003
    Inventors: Peter Lind, Torsten Sejlitz, Gabriel Vogeli, Linda S. Wood
  • Publication number: 20020137132
    Abstract: The present invention provides a gene encoding a G protein-coupled receptor termed nGPCR-2037; constructs and recombinant host cells incorporating the genes; the nGPCR-2037 polypeptides encoded by the gene; antibodies to the nGPCR-2037 polypeptides; and methods of making and using all of the foregoing.
    Type: Application
    Filed: April 6, 2001
    Publication date: September 26, 2002
    Inventors: Gabriel Vogeli, Peter Lind, Torsten Sejlitz, Malin Berthold
  • Patent number: 5721114
    Abstract: The invention relates to an expression system giving high extracellular production of apolipoprotein AI-M (Milano) using E. coli and comprises a plasmid carrying an origin of replication, an inducible promoter sequence, a DNA sequence coding for a signal peptide, a DNA sequence coding for apolipoprotein AI-M, and a transcription terminator. The invention also relates to a method of producing apolipoprotein AI-M using the expression system.
    Type: Grant
    Filed: August 25, 1995
    Date of Patent: February 24, 1998
    Assignee: Pharmacia & Upjohn Aktiebolag
    Inventors: Lars Abrahamsen, Erik Holmgren, Christina Kalderen, Mats Lake, .ANG.sa Mikaelsson, Torsten Sejlitz